Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Medicine Man Technologies Inc (OP: SHWZ )

0.0200 +0.0189 (+1718.18%)
Streaming Delayed Price Updated: 2:38 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,551
Open 0.0200
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0011
Today's Range 0.0200 - 0.0200
52wk Range 0.0011 - 1.380
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip
Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down 3% in November. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Ka-Ching! Schwazze's Cannabis Accounting Bloopers And Other Historic Missteps That Shook Up Big Business
While Schwazze's issue may seem minor compared to past scandals, it serves as a reminder of how easily financial mistakes can spiral. 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
N/A
N/A
1 Month
+98.02%
+98.02%
3 Month
-80.00%
-80.00%
6 Month
-81.82%
-81.82%
1 Year
-98.51%
-98.51%

More News

Read More
Schwazze's Q3 Preliminary Revenue Slides As Debt Grows, 2023 Financials Face Re-Audit
Via Benzinga
Is Colorado's Cannabis Market Back On Track? A 5% Sales Boost Says Yes
Via Benzinga
Topics Cannabis
Exposures Cannabis
Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Schwazze Q2 Revenue Up 2% YoY, Net Loss Rises And Debt Remains High
Via Benzinga
Medicine Man Technologies: Q4 Earnings Insights
Via Benzinga
Earnings Outlook For Medicine Man Technologies
Via Benzinga
Don't Let Hidden Debt Fool You: How Cannabis Investors Can Tell If They Are Safe
Via Benzinga
Topics Cannabis
Exposures Cannabis
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Out Of Pocket: Which U.S. Cannabis Company Owes The Most Money In 2024?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Companies About To Release Earnings Reports, Get Your News Here: Glass House, Schwazze And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks React To Biden Announcement: Monday's Closing Market Moves
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Cannabis Stocks Surge Then Plummet On News That Biden Is Bowing Out Of 2024 Presidential Race
Via Benzinga
Topics Cannabis
Exposures Cannabis
Schwazze Restructures Its $32M Debt Obligations, Improving Financials To Grow Across Colorado And New Mexico
Via Benzinga
7 Cannabis Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Schwazze Cannabis Co Transitions To OTC Expert Market Due To Delayed Filing
Via Benzinga
Topics Cannabis
Exposures Cannabis
Here's Where To Buy Legal Weed: Nevada's Deep Roots Harvest Has New Owner, Shops In Three States That Just Launched Sales
Via Benzinga
Topics Cannabis
Exposures Cannabis
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Schwazze's Q1 2024 Financial Results: Takes A Hit In Colorado, Overall Cannabis Sales Up By 9%
Via Benzinga
Topics Cannabis
Exposures Cannabis
Who's Who In Cannabis: Latest Executive Changes You Should Know About
Via Benzinga
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
Via Benzinga
Topics Cannabis
Exposures Cannabis
Schwazze Records 8% Revenue Growth In Q4 2023 Amid Competitive Cannabis Retail Landscape (CORRECTED)
Via Benzinga
Topics Cannabis
Exposures Cannabis
SHWZ Stock Earnings: Medicine Man Technologies Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.